Edgewise Therapeutics, Inc. ($EWTX)
Filing Information
| Accession Number | 0001853529-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
129,025
Total Value
$258,042.47
P&L
+inf% (+$4,306,575.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 5,781 | $0.00 | $0.00 | 30,336 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 7,031 | $0.00 | $0.00 | 37,367 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 3,238 | $43.68 | $141,427.74 | 34,129 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 2,273 | $43.68 | $99,275.32 | 31,856 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 390 | $44.46 | $17,339.40 | 31,466 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 5,781 | $0.00 | $0.00 | 11,563 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 7,031 | $0.00 | $0.00 | 21,094 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Aug 12, 2026 | Grant/Award | 32,500 | $0.00 | $0.00 | 32,500 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 12, 2026 | Grant/Award | 65,000 | $0.00 | $0.00 | 65,000 | Direct | โ | View Details |